Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy

BACKGROUND: We studied the genetic fingerprints of ovarian cancer and validated the potential of Mammaglobin b (SCGB2A1), one of the top differentially expressed genes found in our analysis, as a novel ovarian tumour rejection antigen. METHODS: We profiled 70 ovarian carcinomas including 24 serous (...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellone, S, Tassi, R, Betti, M, English, D, Cocco, E, Gasparrini, S, Bortolomai, I, Black, J D, Todeschini, P, Romani, C, Ravaggi, A, Bignotti, E, Bandiera, E, Zanotti, L, Pecorelli, S, Ardighieri, L, Falchetti, M, Donzelli, C, Siegel, E R, Azodi, M, Silasi, D-A, Ratner, E, Schwartz, P E, Rutherford, T J, Santin, A D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721400/
https://www.ncbi.nlm.nih.gov/pubmed/23807163
http://dx.doi.org/10.1038/bjc.2013.315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721400/
https://www.ncbi.nlm.nih.gov/pubmed/23807163
http://dx.doi.org/10.1038/bjc.2013.315

Ejemplares similares